- Home
- SUNS vs COYA Comparison
SUNS vs COYA Comparison
Compare SUNS & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUNS | COYA |
|---|---|---|
| Founded | 2023 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.2M | 126.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | SUNS | COYA |
|---|---|---|
| Price | $9.30 | $4.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $13.00 | ★ $15.80 |
| AVG Volume (30 Days) | 99.5K | ★ 302.7K |
| Earning Date | 03-05-2026 | 03-17-2026 |
| Dividend Yield | ★ 12.90% | N/A |
| EPS Growth | ★ 1112.46 | N/A |
| EPS | ★ 1.09 | N/A |
| Revenue | ★ $19,384,703.00 | $3,987,706.00 |
| Revenue This Year | $165.88 | $70.00 |
| Revenue Next Year | $46.38 | N/A |
| P/E Ratio | $8.52 | ★ N/A |
| Revenue Growth | ★ 2540.16 | N/A |
| 52 Week Low | $7.80 | $3.94 |
| 52 Week High | $12.35 | $8.29 |
Technical Indicators
Market Signals| Indicator | SUNS | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 44.49 | 38.18 |
| Support Level | $9.08 | $4.41 |
| Resistance Level | $9.54 | $4.97 |
| Average True Range (ATR) | 0.20 | 0.29 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 40.74 | 43.84 |
Price Performance
Historical ComparisonAbout SUNS Sunrise Realty Trust Inc.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.